GLP-1 for 6 Year Olds? Here’s What the Trial Actually Found
Is obesity still a disease worthy of treatment when the patient is six years old?This week, Novo Nordisk released Phase 3 STEP Young data in children ages 6 to 11 with obesity. After 68 weeks, 40.4% o...
8 Syys 25min
We’re Solving Obesity. Now Who Pays for It?
This week on On The Pen, the GLP-1 story is moving in two very different directions.The Fifth Circuit handed FDA major wins in the fight over semaglutide and tirzepatide shortages, FDA updated its con...
2 Syys 24min
GLP-1 Coverage Is COLLAPSING in 2027
GLP-1 access is getting tighter just as obesity treatment is becoming more effective, more affordable, and more important to public health.In this episode of the On The Pen Podcast, Dave Knapp breaks ...
26 Elo 34min
$50 Zepbound Incoming? China Has US in a GLP-1 “Chokehold”
Could GLP-1 medications eventually cost just $40 to $50 per month? Hims & Hers CEO Andrew Dudum thinks so, and if he’s right, it could completely change access to obesity treatment in America.But gett...
18 Elo 45min
200 GLP-1 Deaths, Chrissy Metz & a Stunning Harvard Study
Https://www.otplinks.comBased on the transcript flow, here’s a clean YouTube description with chapter timestamps. The transcript itself doesn’t include timecodes, so these are estimated from speaking ...
12 Elo 31min
Eli Lilly Earnings Call Recap: Retatrutide News
https://www.otplinks.com
7 Elo 59min
Novo Nordisk Warned us For Years About Synthesized Semaglutide. Now They Want In.
Novo Nordisk has spent years warning patients, regulators, lawmakers, and courts about the risks of synthetic semaglutide. Now, as patents begin to expire and China’s pharmaceutical industry becomes i...
4 Elo 18min
Retatrutide Biologic Battle: The Story Gets Bigger
https://www.otplinks.comhttps://www.voafit.com/otpEpisode Referenced: https://www.youtube.com/watch?v=K8kaSoFCZ0c&t=41sThe retatrutide biologic fight is bigger than folks understand.This breakdown cov...
28 Heinä 20min
